Russian Pharmaceutical Company Promomed Has Opened a New Research Unit in China.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
A subsidiary of the Russian company Promomed was inaugurated in China, at the headquarters of the commercial representation of Russia, declared the president of the board of directors of the pharmaceutical company, Piotr Beli. He explained that the priority will be to ensure the availability of medicines for the treatment of diseases both in Russia and abroad.
The opening of the Chinese branch of the PROMOMED company was held at the Russian Trade Representative Office in China on November 13.
Russian biopharmaceutical company Promomed has inaugurated a new research unit at the Russian Trade Representative Office in China. The unit will focus on joint drug development and clinical research activities between the two countries.
Promomed, a Russian biopharmaceutical company, opened its international unit in China, told RIA News to companies.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
